Truvada Tablets

Truvada Tablets

Brand Name: Truvada
Contents: Emtricitabine 200 mg +Tenofovir disoproxil fumarate 300 mg
Form: Tablets
Manufacturer Gilead Sciences Ltd
Pricing: Price Per Pack of 30 Tablets

INDICATIONS  
Truvada is indicated in combination with other antiretroviral agents (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors) for the treatment of HIV-1 infection in adults.

The following points should be considered when initiating therapy with Truvada for the treatment of HIV-1 infection:
It is not recommended that Truvada be used as a component of a triple nucleoside regimen.
Truvada should not be coadministered with lamivudine+tenofovir DF+Efavirenz, emtricitabine, tenofovir DF or lamivudine-containing products [see WARNINGS AND PRECAUTIONS ] .
In treatment experienced patients, the use of Truvada should be guided by laboratory testing and treatment history.

DOSAGE AND ADMINISTRATION
The dosage of Truvada is one tablet (containing 200 mg of emtricitabine and 300 mg of tenofovir DF) once daily taken orally with or without food.

Pediatric Use
Safety and effectiveness in pediatric patients have not been established.

Geriatric Use
Clinical studies of emtricitabine or tenofovir DF did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects. In general, dose selection for elderly patients should be cautious, keeping in mind the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

CONTRAINDICATIONS
None.

PACKAGING INFORMATION
Truvada tablets ……………. Container of 30 tablets